RXST Q2 2023 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$21M+83.2% YoY

Gross Profit

$12M57.7% margin

Operating Income

-$14M-65.5% margin

Net Income

-$14M-66.3% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+19.0%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$195M

Total Liabilities

$38M

Stockholders' Equity

$157M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$11M	+83.2%
Gross Profit	$12M	$5M	+150.9%
Operating Income	-$14M	-$16M	+13.7%
Net Income	-$14M	-$17M	+17.5%

Revenue Segments

L D D

$8M92%

Service Warranty Service Contracts And Accessories

$679,0008%